Why Weight Loss Plateaus on Semaglutide Weight loss plateaus are a normal part of the process and do not necessarily mean the medication has stopped working
Vascular dementia is driven by the same conditions GLP-1 drugs treat directly: hypertension, hyperglycemia, obesity, and stroke risk
Challenges in transitioning between medications The transition from semaglutide to tirzepatide may not be as simple as stopping the other medication in favor of starting the other
doi: 10.1155/2012/163106 139
216 It is known that changes in GFR can affect the elimination of many drugs including narrow therapeutic index drugs (aminoglycosides, lithium, digoxin), diuretics, and nonsteroidal anti-inflammatory drugs
Strinic D, Belosic Halle Z, Luetic K, Nedic A, Petrovic I, Sucic M, Zivanovic Posilovic G, Balenovic D, Strbe S, Udovicic M, Drmic D, Stupnisek M, Lovric Bencic M, Seiwerth S, Sikiric P